BILL & MELINDA GATES FOUNDATION
We are partnering to develop a large animal neuroclinical pipeline to advance the therapeutic landscape for birth asphyxia worldwide.
National institute for child health and human disease
We are working with Omniox, Inc. on a Fast Track Phase I/II SBIR award to develop a novel oxygen delivery biotherapeutic to help minimize the cardiac dysfunction associated with cardiopulmonary bypass in infants undergoing corrective repair of their congenital heart defects.
multidisciplinary association for psychedelic studies (MAPS)
In partnership with MAPS, we are conducting Phase I clinical trials evaluating the safety of MDMA in the treatment of post-traumatic stress disorder (PTSD).